Business Segments · Net Interest Expense

Reportable Segment — Net Interest Expense

Amgen Reportable Segment — Net Interest Expense decreased by 1.3% to $685.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from $776.00M to $685.00M.

Analysis

StatementSegment
First reportedQ1 2024
Last reportedQ3 2025
Metric ID: amgn_segment_reportable_segment_interest_expense_net

Historical Data

6 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$824.00M$808.00M$776.00M$723.00M$694.00M$685.00M
QoQ Change—-1.9%-4.0%-6.8%-4.0%-1.3%
YoY Change———-12.3%-14.1%-11.7%
Range$685.00M – $824.00M
CAGR-13.7%
Avg YoY Growth-12.7%
Median YoY Growth-12.3%
Current Streak5+ quarters decline

Frequently Asked Questions

What is Amgen's reportable segment — net interest expense?
Amgen (AMGN) reported reportable segment — net interest expense of $685.00M in Q3 2025.
How has Amgen's reportable segment — net interest expense changed year-over-year?
Amgen's reportable segment — net interest expense decreased by 11.7% year-over-year, from $776.00M to $685.00M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.